Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Shoulder Innovations, Inc.NYSE: SI
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables rises 60.2% from a year ago
Net receivables stood at $10.55M at the end of Q1 FY2026, up 60.2% from a year earlier and up 27.6% from the prior quarter.
Context
- Net receivables amounted to 6.6% of total assets at the end of Q1 FY2026, down 4.9 pp from a year earlier.
- Net receivables increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +60.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 8.27M USD
- Year-over-year change
- +61.4%
- 2-year CAGR
- +32.7%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.27M | +61.4% |
| FY2024 | 2024-12-31 | 5.12M | +9.1% |
| FY2023 | 2023-12-31 | 4.69M | — |
Net Receivables vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 net receivables of $10.55M is the 4th highest of the 11 companies compared; the peer median is $4.01M.
- Its year-over-year change of +60.2% is the 2nd highest of 9, against a peer median of +12.1%.
- Net receivables amounts to 6.6% of total assets for SI, versus a peer median of 1.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $41.87M | +14.3% | -15.5% | 14.6% | |
| Mar 2026 | $25.32M | -31.4% | +0.3% | 10.2% | |
| Jun 2026 | $14.93M | -5.0% | +16.3% | 11.3% | |
| Mar 2026 | $10.55M | +60.2% | — | 6.6% | |
| Mar 2026 | $7.83M | -80.7% | -48.0% | 2.5% | |
| Mar 2026 | $6M | +55.2% | +10.4% | 16.2% | |
| Dec 2025 | $2.01M | +11.5% | +27.2% | 1.2% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $665.42K | +179.0% | — | 0.5% |
| Mar 2026 | $451K | +12.8% | +1.0% | 0.2% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SI) | $4.01M | +12.1% | +1.0% | 1.9% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.